Deep-learning-based virtual screening of antibacterial compounds.

This work integrates small-molecule high-throughput screening with a deep-learning-based virtual screening approach to uncover new antibacterial compounds, illustrating a 90-fold improved hit rate over the high-throughput screening experiment used for training.